Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade

Antibodies targeting the co-inhibitory receptor programmed cell death 1 (PDCD1, best known as PD-1) or its main ligand CD274 (best known as PD-L1) have shown some activity in patients with metastatic triple-negative breast cancer (TNBC), especially in a recent Phase III clinical trial combining PD-L...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Pilones, Karsten A., Hensler, Michal, Daviaud, Camille, Kraynak, Jeffrey, Fucikova, Jitka, Galluzzi, Lorenzo, Demaria, Sandra, Formenti, Silvia C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583495/
https://ncbi.nlm.nih.gov/pubmed/33150045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1830524
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia